1 |
中国医师协会甲状腺肿瘤消融治疗技术专家组, 中国抗癌协会甲状腺癌专业委员会, 中国医师协会介入医师分会超声介入专业委员会, 等. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗专家共识(2018版) [J]. 中国肿瘤, 2018, 27(10): 768-773.
|
2 |
浙江省抗癌协会甲状腺肿瘤专业委员会. 甲状腺良性结节、微小癌及颈部转移性淋巴结热消融治疗浙江省专家共识(2015版) [J]. 中国普通外科杂志, 2016, 25(7): 944-946.
|
3 |
Paajanen I, Metso S, Jaatinen P, et al. Thyroid FNA diagnostics in a real-life setting: Experiences of the implementation of the Bethesda system in Finland [J]. Cytopathology, 2018, 29(2): 189-195.
|
4 |
Wesoła M, Jeleń M. Bethesda System in the evaluation of thyroid nodules: Review [J]. Adv Clin Exp Med, 2017, 26(1): 177-182.
|
5 |
Liu S, Gao A, Zhang B, et al. Assessment of molecular testing in fine-needle aspiration biopsy samples: An experience in a Chinese population [J]. Exp Mol Pathol, 2014, 97(2): 292-297.
|
6 |
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid, 2016, 26(1): 1-133.
|
7 |
Spiezia S, Garberoglio R, Milone F, et al. Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation [J]. Thyroid, 2009, 19(3): 219-225.
|
8 |
Clement SC, van Eck-Smit BL, van Trotsenburg AS, et al. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance [J]. Pediatr Blood Cancer, 2013, 60(11): 1833-1838.
|
9 |
Little MP, Kwon D, Zablotska LB, et al. Impact of Uncertainties in Exposure Assessment on Thyroid Cancer Risk among Persons in Belarus Exposed as Children or Adolescents Due to the Chernobyl Accident [J]. PLoS One, 2015, 10(10): e0139826.
|
10 |
郑佳利,李娟,邹晓攀, 等. 超声引导下Ⅰ型胸骨后甲状腺肿微波消融治疗的可行性及临床疗效 [J]. 检验医学与临床, 2017, 14(8): 1095-1097.
|
11 |
郑炳行,师天雄,邓建伟. 胸骨后甲状腺肿98例外科治疗分析[J/CD]. 中华普通外科学文献(电子版), 2014, 8(1): 24-27.
|
12 |
Lee YC, Na SY, Chung H, et al. Clinicopathologic characteristics and pattern of central lymph node metastasis in papillary thyroid cancer located in the isthmus [J]. Laryngoscope, 2016, 126(10): 2419-2421.
|
13 |
张晓晓,詹维伟,周伟, 等. 术前超声检查评估甲状腺微小乳头状癌颈部淋巴结转移的临床价值 [J/CD]. 中华医学超声杂志(电子版), 2014, 11(11): 52-56.
|
14 |
Feng J, Gan X, Shen F, et al. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis [J]. Int J Surg, 2018, 52: 166-170.
|
15 |
徐倪侦,田文,费阳. 40例分化型甲状腺癌术后骨转移时间的影响因素分析 [J]. 解放军医学院学报, 2017, 38(12): 1114-1117, 1126.
|
16 |
Capezzone M, Marchisotta S, Cantara S, et al. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity [J]. Endocr Relat Cancer, 2008, 15(4): 1075-1081.
|
17 |
Moses W, Weng J, Kebebew E. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer [J]. Thyroid, 2011, 21(4): 367-371.
|
18 |
Ito Y, Kakudo K, Hirokawa M, et al. Biological behavior and prognosis of familial papillary thyroid carcinoma [J]. Surgery, 2009, 145(1): 100-105.
|
19 |
Fridman M, Lam AK, Krasko O, et al. Morphological and clinical presentation of papillary thyroid carcinoma in children and adolescents of Belarus: the influence of radiation exposure and the source of irradiation [J]. Exp Mol Pathol, 2015, 98(3): 527-531.
|
20 |
Nixon IJ, Ganly I, Patel SG, et al. Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy [J]. Surgery, 2012, 151(4): 571-579.
|
21 |
Oh HS, Kwon H, Song E, et al. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Carcinoma [J]. Thyroid, 2019, 29(5): 642-649.
|
22 |
Nath MC, Erickson LA. Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid [J]. Adv Anat Pathol, 2018, 25(3): 172-179.
|
23 |
石臣磊,郭勇,吕一辰, 等. 适合手术的甲状腺微小乳头状癌患者临床病理特征 [J]. 中华肿瘤杂志, 2017, 39(5): 361-366.
|
24 |
高明,葛明华,嵇庆海, 等. 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版) [J]. 中国肿瘤临床, 2016, 43(10): 526-526.
|
25 |
孔月,程志刚,韩治宇, 等. 移动消融技术在微波消融治疗甲状腺良性结节中的应用价值 [J]. 解放军医学院学报, 2014, 35(7): 660-662.
|
26 |
Liang P, Dong BX, Yang Y, et al. Prognostic factors for percutaneous microwave coagulation therapy of hepatic metastases [J]. Am J Roentgenol, 2003, 181(5): 1319-1325.
|
27 |
Vuong NL, Dinh LQ, Bang HT, et al. Radiofrequency Ablation for Benign Thyroid Nodules: 1-Year Follow-Up in 184 Patients [J]. World J Surg, 2019, 43(10): 2447-2453.
|
28 |
Liu YJ, Qian LX, Liu D, et al. Ultrasound-guided microwave ablation in the treatment of benign thyroid nodules in 435 patients [J]. Exp Biol Med (Maywood), 2017, 242(15): 1515-1523.
|
29 |
Ding M, Tang X, Cui D, et al. Clinical outcomes of ultrasound-guided radiofrequency ablation for the treatment of primary papillary thyroid microcarcinoma [J]. Clin Radiol, 2019, 74(9): 712-717.
|
30 |
Zhou W, Chen Y, Zhang L, et al. Percutaneous Microwave Ablation of Metastatic Lymph Nodes from Papillary Thyroid Carcinoma: Preliminary Results [J]. World J Surg, 2019, 43(4): 1029-1037.
|
31 |
刘新承,郝少龙,陈焕杰, 等. 甲状腺乳头状癌热消融治疗后再手术11例分析 [J/CD]. 中华普外科手术学杂志(电子版), 2018, 12(4): 299-301.
|
32 |
马奔,王宇,嵇庆海, 等. 原发性甲状腺癌热消融治疗后再手术2例分析 [J]. 中国实用外科杂志, 2016, 36(8): 875-879.
|